Skip to main content

STO 50 (Carbidopa, Entacapone and Levodopa 12.5 mg / 200 mg / 50 mg)

Pill with imprint STO 50 is Red, Round and has been identified as Carbidopa, Entacapone and Levodopa 12.5 mg / 200 mg / 50 mg. It is supplied by Mylan Pharmaceuticals Inc.

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 12.5 mg / 200 mg / 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for STO 50

Carbidopa, Entacapone and Levodopa

Imprint
STO 50
Strength
12.5 mg / 200 mg / 50 mg
Color
Red
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-8300 (Discontinued)
Inactive Ingredients
corn starch, croscarmellose sodium, glycerin, hypromelloses, magnesium stearate, mannitol, polysorbate 80, povidone, sucrose, ferric oxide red, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "STO 50"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.